Health ❯ Cancer ❯ Pancreatic Cancer ❯ Treatment

Clinical Trials

Ben Sasse Reports 76% Tumor Reduction on Experimental Pancreatic Cancer Drug

Early Phase 3 data show the RAS‑targeting pill extended median survival over chemotherapy.

Personalized mRNA Vaccine Shows Durable Survival Signal in Early Pancreatic Cancer

Revolution Medicines Drug Nearly Doubles Survival in Phase 3 Pancreatic Cancer Trial

Ben Sasse Details Tumor Shrinkage and Harsh Side Effects in Frank Cancer Interview